Results 161 to 170 of about 1,287,974 (192)
Some of the next articles are maybe not open access.
Genitourinary Syndrome of Menopause
Medical Clinics of North America, 2023Introduced in 2014, genitourinary syndrome of menopause (GSM) describes a variety of unpleasant genital, sexual and urinary symptoms that can either be isolated or coexisting and are not related to other medical conditions. GSM is a chronic and progressive condition that requires early recognition and appropriate management to preserve urogenital ...
Shanice, Cox +3 more
openaire +2 more sources
Role of Estradiol and C-Reactive Protein Levels on Genitourinary Syndrome in Menopausal Women [PDF]
Narra JMenopause leads to decreased estradiol levels affecting tissue health and causing local inflammation in the genital organs and urinary tract. The rise of blood C-reactive protein (CRP) levels in menopausal women may indicate systemic inflammation ...
Masakazu Terauchi +2 more
exaly +2 more sources
Characteristics of Post-Menopausal Women With Genitourinary Syndrome of Menopause: Implications for Vulvovaginal Atrophy Diagnosis and Treatment Selection [PDF]
Maturitas, 2015 BACKGROUND: Vulvovaginal atrophy (VVA), also known as genitourinary syndrome of menopause, exerts a negative impact on the sexuality, health and quality of life of post-menopausal women.
Marco Anelli +2 more
exaly +2 more sources
Hormonal Medications for Genitourinary Syndrome of Menopause
Clinical Obstetrics & Gynecology, 2023Genitourinary syndrome of menopause is a common, under-reported, and undertreated chronic progressive condition requiring long-term treatment. Hypoestrogenism in the urogenital tissues is associated with bothersome dyspareunia, vulvovaginal symptoms, overactive bladder, and frequent urinary tract infections. Vaginal hormone therapies, including vaginal
JoAnn V, Pinkerton +2 more
openaire +2 more sources
Genitourinary syndrome of menopause: the unmet need
Menopause, 2021Abstract Genitourinary syndrome of menopause (GSM) is a highly prevalent and progressive condition of postmenopausal women that has significant negative effects on vulvovaginal health, sexual health, and overall quality of life. Despite many available safe and effective therapies, GSM often goes undiagnosed and untreated.
Susan Kellogg, Spadt, Lisa C, Larkin
openaire +2 more sources
Treatment of the genitourinary syndrome of menopause
Climacteric, 2015The vagina, vulva, vestibule, labia majora/minora, and bladder trigone have a high concentration of estrogen receptors; therefore, they are a sensitive biological indicator of serum levels of these hormones in women. The estrogen loss in postmenopausal women produces a dysfunction called genitourinary syndrome of menopause.
S, Palacios, A, Mejía, J L, Neyro
openaire +2 more sources
Deconstructing the genitourinary syndrome of menopause
International Urogynecology Journal, 2017The concept of genitourinary syndrome of menopause (GSM) was recently introduced and has been gaining widespread use. While some justifications for its introduction are straightforward, others may be questionable. Numerous unspecific symptoms and signs were included in the definition of the syndrome, but the minimum number required for diagnosis was ...
Pedro Vieira-Baptista +4 more
openaire +3 more sources
Genitourinary Syndrome of Menopause
Clinical Obstetrics & Gynecology, 2018Genitourinary syndrome of menopause (GSM) describes a collection of exam findings and bothersome symptoms associated with estrogen deficiency involving changes to the labia, introitus, clitoris, vagina, urethra, and bladder. Vulvovaginal atrophy is a component of GSM.
openaire +4 more sources
Genitourinary Syndrome of Menopause in Cancer Survivors
Clinical Obstetrics & Gynecology, 2023Genitourinary syndrome of menopause (GSM) encompasses the symptoms of estrogen deprivation in the vaginal, vulva, and bladder areas. Because many cancer treatments induce a hypoestrogenic state, GSM is common in cancer survivors. The number of cancer survivors is increasing, and the unique aspects of GSM management for cancer survivors, such as the ...
Catherine L, Dugan +2 more
openaire +2 more sources
Genitourinary Syndrome of Menopause: Prevalence and Predictors
Clinical Obstetrics & Gynecology, 2023The genitourinary syndrome of menopause (GSM) has been proposed as a diagnosis by a consensus of clinicians and investigators. Our purpose for this paper is to review extant evidence about: 1) the breadth of symptoms and symptom clusters as related to the syndrome; 2) the prevalence of GSM (includes vulvar and vaginal atrophy); 3) factors that are ...
NANCY F. WOODS +2 more
openaire +2 more sources